Alberts DS - Search Results

1

In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs.

Alberts DS, Dorr RT, Wunz TP, Remers WA, Einspahr J, Liu R, Salmon SE. Alberts DS, et al. Anticancer Drugs. 1991 Feb;2(1):69-77. doi: 10.1097/00001813-199102000-00010. Anticancer Drugs. 1991. PMID: 1958855

2

Structure-activity relationships for mitomycin C and mitomycin A analogues.

Kunz KR, Iyengar BS, Dorr RT, Alberts DS, Remers WA. Kunz KR, et al. Among authors: alberts ds. J Med Chem. 1991 Jul;34(7):2281-6. doi: 10.1021/jm00111a051. J Med Chem. 1991. PMID: 1906109

3

Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.

Bellamy WT, Dorr RT, Dalton WS, Alberts DS. Bellamy WT, et al. Among authors: alberts ds. Cancer Res. 1988 Nov 15;48(22):6360-4. Cancer Res. 1988. PMID: 3180055

4

Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.

Sami SM, Dorr RT, Sólyom AM, Alberts DS, Remers WA. Sami SM, et al. Among authors: alberts ds. J Med Chem. 1995 Mar 17;38(6):983-93. doi: 10.1021/jm00006a018. J Med Chem. 1995. PMID: 7699715

5

In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.

Federico M, Alberts DS, Garcia DJ, Emerson J, Fanta P, Liu R, Salmon SE. Federico M, et al. Among authors: alberts ds. Gynecol Oncol. 1994 Dec;55(3 Pt 2):S156-63. doi: 10.1006/gyno.1994.1356. Gynecol Oncol. 1994. PMID: 7835801

6

Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells.

Shipp NG, Dorr RT, Alberts DS, Dawson BV, Hendrix M. Shipp NG, et al. Among authors: alberts ds. Cancer Res. 1993 Feb 1;53(3):550-6. Cancer Res. 1993. PMID: 8425187

7

2-substituted 1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. A new class of antitumor agent.

Sami SM, Dorr RT, Alberts DS, Remers WA. Sami SM, et al. Among authors: alberts ds. J Med Chem. 1993 Mar 19;36(6):765-70. doi: 10.1021/jm00058a014. J Med Chem. 1993. PMID: 8459403

8

6- and 7-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h] isoquinoline-1,3-diones: synthesis, nucleophilic displacements, antitumor activity, and quantitative structure-activity relationships.

Sami SM, Dorr RT, Sòlyom AM, Alberts DS, Iyengar BS, Remers WA. Sami SM, et al. Among authors: alberts ds. J Med Chem. 1996 Apr 12;39(8):1609-18. doi: 10.1021/jm950742g. J Med Chem. 1996. PMID: 8648600

9

Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor.

Dorr RT, Dvorakova K, Snead K, Alberts DS, Salmon SE, Pettit GR. Dorr RT, et al. Among authors: alberts ds. Invest New Drugs. 1996;14(2):131-7. doi: 10.1007/BF00210783. Invest New Drugs. 1996. PMID: 8913833

10

2-[2'-(Dimethylamino)ethyl]-1,2-dihydro- 3H-dibenz[de,h]isoquinoline-1,3-diones with substituents at positions 4, 8, 9, 10, and 11. Synthesis, antitumor activity, and quantitative structure-activity relationships.

Sami SM, Dorr RT, Alberts DS, Sólyom AM, Remers WA. Sami SM, et al. Among authors: alberts ds. J Med Chem. 1996 Dec 6;39(25):4978-87. doi: 10.1021/jm960623g. J Med Chem. 1996. PMID: 8960558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

616 results

Search Page

Filters